Viewing Study NCT01145768


Ignite Creation Date: 2025-12-24 @ 5:48 PM
Ignite Modification Date: 2026-01-01 @ 10:54 AM
Study NCT ID: NCT01145768
Status: COMPLETED
Last Update Posted: 2010-12-08
First Post: 2010-06-07
Is NOT Gene Therapy: True
Has Adverse Events: False

Brief Title: To Investigate the Safety and Tolerability of TC-5214 Following Oral Administration of Multiple Doses for up to 8 Days
Sponsor: AstraZeneca
Organization:

Study Modules

Identification Module Status Module Sponsor Collaborators Module Oversight Module Description Module Conditions Module Design Module Arms Interventions Module Outcomes Module Eligibility Module Contacts Locations Module References Module